Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2339.00    1.00 (0.04%)
Bid:
2344.00
Ask:
2345.00
Spread: 1.00 (0.043%)
Market Cap: £28.21b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Director/PDMR Shareholding

5 Jun 2026 12:39

RNS Number : 2461H
SSE PLC
05 June 2026
 

SSE plc

Director/PDMR Shareholding

SSE plc (the "Company") - Notification of Transactions of Directors/Persons Discharging Managerial Responsibilities and their Closely Associated Persons

 

(i) Deferred Bonus Scheme (DBS) - Grant of Awards - 4 June 2026

On 4 June 2026 the independent Trustee of the SSE Employee Trust notified the Company that it had on 4 June 2026 granted the Directors/PDMRs listed in the table that follows awards over Ordinary shares of 50 pence each fully paid in the Company under the DBS. The number of shares under each award has been calculated by reference to a price of £23.00 per share, being the average of the Company's share price over the three dealing days immediately preceding the date of grant.

Awards granted under the DBS represent a deferral of a proportion of the cash bonus earned for the 2025/26 annual incentive year which is converted into shares. The shares will vest after a period of three years from the date of grant subject normally to the participant remaining in employment with the Company. On vesting, the participant will become entitled to additional shares representing the value of reinvested dividends over the three-year period. 

 

 

 

 

 

1

 

Details of the person(s) discharging managerial responsibilities/person closely associated with

a)

Name(s)

Martin Pibworth (Director)

Barry O'Regan (Director)

Christopher Burchell (PDMR)

Nikki Flanders (PDMR)

Rhian Kelly (PDMR)

Finlay McCutcheon (PDMR)

Robert McDonald (PDMR)

Sam Peacock (PDMR)

John Stewart (PDMR)

Elizabeth Tanner (PDMR)

Stephen Wheeler (PDMR)

 

2

 

Reason for the notification

a)

Position/status

As noted in 1a) above

b)

Initial notification/Amendment

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SSE plc

b)

LEI

549300KI75VYLLMSK856

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 50 pence each fully paid

ISIN: GB0007908733

b)

Nature of transaction

Grant of Awards under the SSE plc Deferred Bonus Scheme

c)

Price(s) and volume(s)

 

 

 

 

 

 

 

 

 

 

 

 

 

Conditional awards of shares, the number of shares calculated by reference to a price of GBP£23.00, being the average of the Company's share price over the three dealing days immediately preceding the date of grant.

 

Director/PDMR

Total DBS Awards Granted

 

Martin Pibworth (Director)

18,224

 

Barry O'Regan (Director)

13,532

 

Christopher Burchell (PDMR)

4,441

 

Nikki Flanders (PDMR)

3,340

 

Rhian Kelly (PDMR)

544

 

Finlay McCutcheon (PDMR)

3,662

 

Robert McDonald (PDMR)

5,557

 

Sam Peacock (PDMR)

2,439

 

 

John Stewart (PDMR)

 

 

2,934

 

Elizabeth Tanner (PDMR)

3,178

 

Stephen Wheeler (PDMR)

4,317

d)

Aggregated information

- Aggregated volume

- Price

 

As noted in 4c) above

As noted in 4c) above

e)

Date of transaction

4 June 2026, date of grant

f)

Place of transaction

Outside a trading venue

 

 

 

(ii) Performance Share Plan (PSP) - Grant of Awards - 4 June 2026

 

On 4 June 2026 the independent Trustee of the SSE Employee Trust notified the Company that it had on 4 June 2026 granted the Executive Directors/PDMRs listed in the table that follows awards over Ordinary shares of 50 pence each fully paid in the Company under the PSP. The number of shares stated will become available to each Executive Director/PDMR if the performance targets applicable to the award are achieved at their upper limit or above. On vesting, the Executive Directors/PDMRs will become entitled to additional shares representing the value of reinvested dividends over the performance period. The number of shares under each award has been calculated by reference to a price of £23.00 per share, being the average of the Company's share price over the three dealing days immediately preceding the date of grant.

 

Vesting of these awards will normally only take place if performance conditions are satisfied over the three-year performance period 1 April 2026 to 31 March 2029. These performance conditions are those indicated in the Remuneration Committee Report which forms part of SSE's 2026 Annual Report and Accounts which will be published on 12 June 2026.

 

Awards granted to Executive Directors will be subject to an additional post-vesting holding period during which time the Executive Director must retain the post-tax number of shares vesting under award.

 

 

1

 

Details of the person(s) discharging managerial responsibilities/person closely associated with

a)

Name(s)

Martin Pibworth (Executive Director)

Barry O'Regan (Executive Director)

Thomas Brostrǿm (PDMR)

Christopher Burchell (PDMR)

Nikki Flanders (PDMR)

Rhian Kelly (PDMR)

Finlay McCutcheon (PDMR)

Robert McDonald (PDMR)

Sam Peacock (PDMR)

John Stewart (PDMR)

Stephen Wheeler (PDMR)

 

2

 

Reason for the notification

a)

Position/status

As noted in 1a) above

b)

Initial notification/Amendment

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SSE plc

b)

LEI

549300KI75VYLLMSK856

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 50 pence each fully paid

ISIN: GB0007908733

b)

Nature of transaction

Grant of Awards under the SSE plc Performance Share Plan

c)

Price(s) and volume(s)

 

 

 

 

 

 

 

 

 

 

 

 

Conditional awards of shares, the number of shares calculated by reference to a price of GBP£23.00, being the average of the Company's share price over the three dealing days immediately preceding the date of grant.

 

Executive Director

Total PSP Awards Granted

Martin Pibworth

136,956

Barry O'Regan

92,065

 

Thomas Brostrǿm (PDMR)

46,956

 

Christopher Burchell (PDMR)

39,624

 

Nikki Flanders (PDMR)

34,650

 

Rhian Kelly (PDMR)

15,525

 

Finlay McCutcheon (PDMR)

34,530

 

Robert McDonald (PDMR)

41,304

 

Sam Peacock (PDMR)

22,305

 

John Stewart (PDMR)

26,828

 

Stephen Wheeler (PDMR)

40,710

d)

Aggregated information

- Aggregated volume

- Price

 

As noted in 4c) above

As noted in 4c) above

e)

Date of transaction

4 June 2026, date of grant

f)

Place of transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSIFFIEMSEDM
Date   Source Headline
4th Dec 20257:01 amRNSSSENT response to RIIO-T3 Final Determination
3rd Dec 202510:10 amRNSHolding(s) in Company
2nd Dec 20252:41 pmRNSHolding(s) in Company
1st Dec 20258:55 amRNSHolding(s) in Company
1st Dec 20257:00 amRNSTotal Voting Rights
28th Nov 202512:42 pmRNSHolding(s) in Company
28th Nov 202512:36 pmRNSHolding(s) in Company
28th Nov 202512:32 pmRNSDirector/PDMR Shareholding
27th Nov 20259:57 amRNSHolding(s) in Company
17th Nov 202511:30 amRNSDirector/PDMR Shareholding
14th Nov 20253:45 pmRNSDirector/PDMR Shareholding
13th Nov 20255:30 pmRNSSSE
12th Nov 20256:19 pmRNSResult of Equity Issue
12th Nov 20257:01 amRNSRetail Offer by RetailBook
12th Nov 20257:00 amRNSInterim Results
12th Nov 20257:00 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
12th Nov 20257:00 amRNSStrategic Update
7th Nov 202512:51 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
24th Oct 20252:30 pmRNSHolding(s) in Company
9th Oct 202511:42 amRNSDirector/PDMR Shareholding
7th Oct 20254:08 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSNOTIFICATION OF CLOSED PERIOD
1st Oct 20257:01 amEQSTotal Voting Rights
25th Sep 202511:00 amRNSDirector/PDMR Shareholding
22nd Sep 202511:46 amRNSDirector/PDMR Shareholding
16th Sep 202512:00 pmRNSAdditional Listing
9th Sep 20254:21 pmRNSDirector/PDMR Shareholding
1st Sep 20257:00 amEQSTVR-Total Voting Rights
29th Aug 20257:00 amRNSBlock Listing 6-Monthly Return
28th Aug 20254:56 pmRNSScrip Alternative
26th Aug 20255:33 pmRNSSSEN TRANSMISSION ISSUES NEW €750m GREEN BOND
8th Aug 202511:12 amRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202510:39 amRNSSCRIP Dividend
31st Jul 202510:38 amRNSHolding(s) in Company
29th Jul 20253:51 pmRNSHolding(s) in Company
25th Jul 202511:05 amRNSHolding(s) in Company
23rd Jul 202512:13 pmRNSHolding(s) in Company
21st Jul 20253:44 pmRNSDirector/PDMR Shareholding
21st Jul 202511:49 amRNSHolding(s) in Company
17th Jul 20253:49 pmRNSResult of AGM
17th Jul 20257:00 amRNSQ1 Trading Statement
11th Jul 202511:00 amRNSDirector/PDMR Shareholding
9th Jul 20254:38 pmRNSDirector/PDMR Shareholding
8th Jul 20255:06 pmRNSDirector/PDMR Shareholding
1st Jul 20259:58 amRNSTotal Voting Rights
1st Jul 20257:09 amRNSSSENT response to RIIO-T3 Draft Determination
13th Jun 20251:15 pmRNSPublication of Annual Report and Accounts 2025
12th Jun 20255:04 pmRNSISSUE OF HYBRID CAPITAL SECURITIES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.